Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report

By              

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1039-1042

Spandidos Publications

Access to resources Recommend Favorite

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

By        

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 931-938

Spandidos Publications

Access to resources Recommend Favorite

Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation

By                    

International Journal of Oncology, Vol. 42, Iss. 6, 2013-01 ,pp. : 2094-2102

Spandidos Publications

Access to resources Recommend Favorite

Clinical usefulness of gefitinib for non-small-cell lung cancer with a double epidermal growth factor receptor mutation

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 329-333

Science Publishers

Access to resources Recommend Favorite

Combined Treatment with Epimedium koreanum Nakai Extract and Gefitinib Overcomes Drug Resistance Caused by T790M Mutation in Non-Small Cell Lung Cancer Cells

By Song Jie   Zhong Rongling   Huang Houcai   Zhang Zhenhai   Ding Dongmei   Yan Hongmei   Sun E   Jia Xiaobin  

Nutrition and Cancer, Vol. 66, Iss. 4, 2014-05 ,pp. : 682-689

Routledge Ltd

Access to resources Recommend Favorite